M. Mita

Preceding bortezomib administration for a certain period reduces the risk of lenalidomide‐induced skin rash

T. Uchida, M. Hagihara, T. Yasu, 2021, Journal of clinical pharmacy and therapeutics.

Analysis of risk factors for lenalidomide-associated skin rash in patients with multiple myeloma

T. Uchida, M. Hagihara, Morihiro Inoue, 2021, Leukemia & lymphoma.

Simple desensitization protocol for multiple myeloma patients with lenalidomide‐induced skin rash: Case series

T. Uchida, M. Hagihara, T. Yasu, 2021, Journal of clinical pharmacy and therapeutics.

[Analysis of clinical factors that influence re-stenosis after percutaneous coronary stenting].

Masaki Saito, R. Ogawa, M. Mita, 2007, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[Successful treatment of pure red cell aplasia with cyclosporine].

T. Uchida, S. Matsuda, S. Kariyone, 1987, [Rinsho ketsueki] The Japanese journal of clinical hematology.